Attached files

file filename
EX-31 - CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER - Capital Group Holdings, Inc.ex312q.htm
EX-31 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Capital Group Holdings, Inc.ex311q.htm
EX-32 - SECTION 1350 CERTIFICATION - Capital Group Holdings, Inc.ex32q12010.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


____________________


FORM 10-Q

____________________


[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended September 30, 2010


[  ] TRANSITION REPORT UNDER SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from ____________ to____________


Commission File No. 000-17064 



CAPITAL GROUP HOLDINGS, INC.

 (Exact name of registrant as specified in its charter)


 

 

Minnesota

41-1430130

(State or other jurisdiction of

(I.R.S. Employer Identification No.)

incorporation or organization)

  


7689 E Paradise Ln. Suite 5

Scottsdale, AZ 85260

 (Address of Principal Executive Offices)


(480) 998-2100

 (Registrant’s telephone number, including area code)



Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]


Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yes [X] No [  ]


Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):


Large accelerated filer [  ]      Accelerated filer [  ]       Non-accelerated filer [  ]      Smaller reporting company [X]


Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes [  ] No [X]

 

Indicate the number of shares outstanding of each of the Registrant’s classes of common stock, as of the latest practicable date: July 20, 2012 - 56,131,121 shares of common stock ($0.01 par value) outstanding.


CAPITAL GROUP HOLDINGS, INC.

Index to Report



1





PART I – FINANCIAL INFORMATION

Page

  

  

  

Item 1.

Financial Statements

3

 

Condensed Consolidated Balance Sheets – September 30, 2010 (unaudited) and June 30, 2010

Condensed Consolidated Statements of Operations – Three Months Ended September 30, 2010 and 2009 (unaudited)

3

4

 

Condensed Consolidated Statements of Cash Flows - Three Months Ended September 30, 2010 and 2009 (unaudited)

5

 

Notes to Condensed Consolidated Financial Statements (unaudited)

6

 

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

14

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

  22

Item 4.

Controls and Procedures

22

 

 

 

PART II – OTHER INFORMATION

  

 

26

Item 1.

Legal Proceedings

26

Item 1A.

Risk Factors

 

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

26

Item 3.

Defaults upon Senior Securities

26

Item 4.

[Reserved]

26

Item 5

Other Information

26

Item 6.

Exhibits

26




2




Part I - FINANCIAL INFORMATION


ITEM 1. Financial Statements


 

CAPITAL GROUP HOLDINGS, INC.

(A DEVELOPMENT STAGE COMPANY)

Condensed Consolidated Balance Sheets

 

 

 

 

 

 

 

 

 

 

 

September 30, 2010

 

June 30, 2010

 

 

 

 

(unaudited)

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

$

84,784

   $

15,006

 

Other current assets

 

7,500

 

12,500

 

Deposits

 

230,000

 

                           -

 

Stock subscription receivable

 

9,257

 

                           -

 

 

Total current assets

 

331,541

 

27,506

 

 

 

 

 

 

 

 

Property and equipment, net of depreciation

 

14,613

 

15,199

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

$

346,154

   $

42,705

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS'  DEFICIT

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

$

173,155

   $

152,044

 

Accounts payable to related party

 

3,665

 

3,665

 

Accrued payroll liabilities

 

430,485

 

396,877

 

Accrued liabilities

 

60,531

 

16,508

 

Convertible notes payable, net of discount for warrants

 

1,883,115

 

844,437

 

 

Total current liabilities

 

2,550,951

 

1,413,531

 

 

 

 

 

 

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS'  DEFICIT

 

 

 

 

 

Common stock, $.01 par value, 100,000,000 shares authorized,

 

 

 

 

 

 

25,635,423 and 19,596,208 shares issued and outstanding as

 

 

 

 

 

 

 of September 30, 2010 and June 30, 2010, respectively

 

256,354

 

195,962

 

Additional paid in capital

 

4,723,159

 

4,548,343

 

Accumulated deficit

 

(3,539,288)

 

(3,539,288)

 

Accumulated deficit during development stage

 

(3,645,022)

 

(2,575,843)

 

 

 

 

 

 

 

TOTAL STOCKHOLDERS'  DEFICIT

 

(2,204,797)

 

(1,370,826)

 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

$

346,154

   $

42,705




See accompanying notes to condensed consolidated financial statements












3












CAPITAL GROUP HOLDINGS, INC.

(A DEVELOPMENT STAGE COMPANY)

Condensed Consolidated Statements of Operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Period from

 

 

 

 

 

 

 

April 26, 2006 (Date

 

 

 

 

 

 

 

of Commencement of

 

 

 

For the

 

For the

 

Development Stage)

 

 

 

Three Months Ended

 

Three Months Ended

 

Through

 

 

 

September 30, 2010

 

September 30, 2009

 

September 30, 2010

 

 

 

(unaudited)

 

(unaudited)

 

(unaudited)

Revenues:

 

 

 

 

 

 

 

Sales

$

                               -

$

                               -

$

                                 -

Total revenues

 

                               -

 

                               -

 

                                 -

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

General and administrative

 

529,084

 

7,052

 

1,520,469

 

Compensation expense

 

473,184

 

49,064

 

1,330,205

 

Due diligence cost on rescinded purchases

 

20,230

 

                               -

 

290,199

Total operating expenses

 

1,022,498

 

56,116

 

3,140,873

 

 

 

 

 

 

 

 

Loss from operations

 

(1,022,498)

 

(56,116)

 

(3,140,873)

 

 

 

 

 

 

 

 

Other Income and Expense

 

 

 

 

 

 

 

Realized loss on sale of marketable securities

 

                               -

 

                               -

 

                    (432,643)

 

Interest income

 

                               -

 

                               -

 

                             1,094

 

Interest expense

 

(46,681)

 

(1,802)

 

(72,600)

Total Other Income (Expense)

 

(46,681)

 

(1,802)

 

(504,149)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET LOSS

$

(1,069,179)

$

(57,918)

$

(3,645,022)

 

 

 

 

 

 

 

 

Loss per share – basic and diluted

$

(0.05)

$

(0.00)

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - Basic and diluted

 

23,664,182

 

19,596,208

 

 






See accompanying notes to condensed consolidated financial statements









4








CAPITAL GROUP HOLDINGS, INC.

(A DEVELOPMENT STAGE COMPANY)

Condensed Consolidated Statements of Cash Flows

 

 

 

 

 

 

 

 

 

 

For the Period from

 

 

 

 

 

 

 

April 26, 2006 (Date

 

 

 

 

 

 

 

of Commencement of

 

 

 

For the

 

For the

 

Development Stage)

 

 

 

Three Months Ended

 

Three Months Ended

 

Through

 

 

 

September 30, 2010

 

September 30, 2009

 

September 30, 2010

 

 

 

(unaudited)

 

(unaudited)

 

(unaudited)

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

 

Net loss

$

                          (1,069,179)

$

                               (57,918)

$

                         (3,645,022)

 

Adjustments to reconcile net loss to net cash

 

 

 

 

 

 

 

  provided by (used in) operating activities:

 

 

 

 

 

 

 

  Depreciation and amortization

 

                                   1,023

 

                                      264

 

                                    4,204

 

  Services provided in exchange for common shares

 

                                            -

 

                                          -   

 

                                 62,500

 

  Stock based compensation

 

                              180,000

 

                                          -   

 

                               362,500

 

  Loss (Gain) on marketable securities

 

                                            -

 

                                          -   

 

                                432,718

 

  Accrued interest and discount on convertible notes payable

 

                                    2,911

 

                                          -   

 

                                    3,956

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

  Accounts payable

 

                                    21,111

 

                                  2,975

 

                                390,815

 

  Accounts payable - related party

 

                                            -

 

                                 (1,402)

 

                                   (1,402)

 

  Accrued payroll and other liabilities

 

                                 77,631

 

                                35,952

 

                               278,423

 

  Prepaid expenses and other deposits

 

                           (225,000)

 

                                      775

 

                             (237,500)

NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES

 

                           (1,011,503)

 

                               (19,354)

 

                         (2,348,808)

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

  Purchase of property and equipment

 

                                    (437)

 

(528)

 

(18,817)

 

  Proceeds from sale of available for sale securities

 

                                            -

 

                                            -

 

                               309,782

NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

 

                                    (437)

 

                                    (528)

 

                               290,965

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

  Issuance of convertible notes payable

 

                             1,081,718

 

                                            -

 

                             1,942,218

 

  Issuance of common stock for cash or collection on subscriptions

 

                                            -

 

21,249

 

195,046

 

  Additional paid in capital

 

                                            -

 

                                            -

 

5,363

NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

 

                             1,081,718

 

                                 21,249

 

                            2,142,627

 

 

 

 

 

 

 

 

NET CHANGE IN CASH

 

                                69,778

 

1,367

 

84,784

CASH BALANCES

 

 

 

 

 

 

 

  Beginning of period

$

                                 15,006

$

                                      434

$

                                             -

 

  End of period

$

                                84,784

$

                                    1,801

$

                                 84,784

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:

 

 

 

 

 

 

 

  Debt discount for fair value of attached warrants

$

                                46,378

$

                                            -

$

                                 63,486

 

  Common stock issued for conversion of notes

$

                                  8,830

$

                                            -

$

                                             -

 

  Shares issued for subscription receivable

$

                                  9,257

$

                                            -

$

                                    9,257

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

 

 

 

 

 

 

     CASH PAID DURING THE YEAR FOR:

 

 

 

 

 

 

 

  Interest

$

                                            -

$

                                            -

$

                                             -

 

  Income taxes

$

                                            -

$

                                            -

$

                                             -



See accompanying notes to consolidated financial statements


5




Capital Group Holdings, Inc.

(A Development Stage Company)

Notes to Condensed Consolidated Financial Statements

(Unaudited)



1.  Organization and Nature of Business


The Company was incorporated as Implant Technologies, Inc. in 1980 under the laws of the State of Minnesota.  On April 26, 2006 the Company entered the development stage when it revived its corporate charter.  On September 17, 2007, the Company changed its name to Oasis Online Technologies, Corp. and began development of technology for secure storage of online data.  During November 2010, the Company changed its name to Capital Group Holdings, Inc. and has focused on developing a Telemedicine platform under the Company’s wholly-owned subsidiary OneHealthPass, Inc.  


For the period from April 26, 2006 (date of commencement of Development Stage) to September 30, 2010, the Company has not generated revenues from operations and has been developing its products, developing markets, securing strategic alliances and securing funding. Therefore, the Company is considered to be in the development stage in accordance with the provisions of ASC 915-10-05, Accounting and Reporting by Development Stage Enterprises.


2.  Summary of Significant Accounting Policies


The accompanying condensed consolidated financial statements have been prepared without audit, pursuant to the rules and regulations of the United States Securities and Exchange Commission.  These financial statements should be read in conjunction with the consolidated financial statements and notes thereto (the “Audited Financial Statements”) contained in the Company’s Annual Report for the fiscal year ended June 30, 2010 on Form 10-K filed with the Securities and Exchange Commission on July 18, 2012.  Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted.  These interim financial statements include all adjustments consisting of normal recurring entries, which in the opinion of management are necessary to present a fair statement of the results for the period. The results of operations for the period ended September 30, 2010 are not necessarily indicative of the operating results for the full year.


Use of Accounting Estimates


The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period.  Generally, the Company’s matters subject to estimation and judgment include amounts related to asset impairments, useful lives of fixed assets, paroll tax liabilities, and stock based compensation.  Actual results may differ from estimates provided.




6




Taxes


At September 30, 2010, management had recorded a full valuation allowance against the net deferred tax assets related to temporary differences and operating losses in the current period because there is significant uncertainty as to the realizability of the deferred tax assets. Based on a number of factors, the currently available, objective evidence indicates that it is more-likely-than-not that the net deferred tax assets will not be realized.


The Company has accrued for unremitted payroll taxes, and employee withholdings due to various state and federal agencies along with accrued interest and penalties on the amounts outstanding as of September 30, 2010 as part of accrued payroll liabilities.


Fair Value of Financial Instruments


ASC 820, Fair Value Measurement, requires disclosure of  fair value information about financial instruments when it is practicable to estimate that value. The carrying amount of the Company’s cash, stock subscriptions receivable, accounts payable, and accounts payable-related party approximate their estimated fair values due to their short-term maturities.  


For assets and liabilities measured at fair value, the Company uses the following hierarchy of inputs:


Level one - quoted market prices in active markets for identical assets or liabilities;


Level two - inputs other than level one inputs that are either directly or indirectly observable; and


Level three - unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.


All cash and cash equivalents, accounts payable, and accrued liabilities approximate their estimated fair value.  Convertible notes payable are carried at fair value based on their carrying amounts less a note discount for the relative fair value of the attached warrants issued with the notes.  The interest accrued on the convertible notes payable are carried at fair value based on 12% interest rates on the notes.  The notes have a maturity of less than one year and are classified as short-term liabilities.  Warrants issued were valued using the Black-Scholes option pricing model, which is a level three input (see note 5).


Recently Issued Accounting Pronouncements


The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its consolidated financial statements.




7




3.  Going Concern and Liquidity


The Company has total accumulated losses as of September 30, 2010 of ($7,184,310), and has had negative cash flows from operating activities during the period from inception through September 30, 2010. These factors raise substantial doubt about the Company’s ability to continue as a going concern.  


If new sources of financing are insufficient or unavailable, we will modify our growth and operating plans to the extent of available funding, if any. Any decision to modify our business plans would harm our ability to pursue our growth plans. If we cease or stop operations, our shares could become valueless. Historically, we have funded operating, administrative and development costs through the sale of equity capital. If our plans and/or assumptions change or prove inaccurate, and we are unable to obtain further financing, or such financing and other capital resources, in addition to projected cash flow, if any, prove to be insufficient to fund operations, our continued viability could be at risk. To the extent that any such financing involves the sale of our equity, our current stockholders could be substantially diluted. There is no assurance that we will be successful in achieving any or all of these objectives in the future.


The Company had not been compliant with SEC reporting deadlines, but management has opted to make the necessary filings to be become compliant with the Securities and Exchange Commission (SEC) reporting guidelines to allow the Company to raise capital in order to execute on the Company’s business strategy.  Management is attempting to raise capital, secure strategic alliances, and to operate the business strategy, however there is no assurance that these will be obtained.


4. Common Stock


Pursuant to the Articles of Incorporation as amended on September 19, 2007, the Company is authorized to issue 100,000,000 common shares, with a par value of $0.01 per share. In connection with the Capital Base Funding Agreement as discussed in Note 8, which ended on December 31, 2007, the Company issued 51,046 shares of the Company’s common stock in exchange for funding totaling $51,046. On October 22, 2007, the Company issued 990,000 shares of common stock in exchange for 99,000 freely trading registered shares of Immunosyn Corporation, a Delaware corporation.


During the three months ended September 30, 2010 and 2009, the Company issued 6,039,215 and 0 shares, respectively. During the three months ended September 30, 2010, the Company  issued 6,000,000 shares for compensation to officers and directors valued at $180,000, and issued 39,215 shares on the conversion of $9,746 of convertible notes payable and $99 of accrued interest


5.  Convertible Notes Payable and Warrants


During the three months ended September 30, 2010 and 2009, the Company issued $1,091,464 and $0 convertible notes payable and 1,091,464 and 0 attached warrants to third party investors in exchange for $1,082,207 and $0 in cash and $9,257 and $0 in stock subscriptions receivable, respectively.  The notes had a one year maturity and bore interest at a rate of 12% per annum,



8




there have been no defaults on the notes.   The notes are convertible into common shares at a conversion price of $0.25 per share with 1,091,464 attached warrants exercisable into common shares at $0.25 per warrant.  As of September 30, 2010, $9,746 in notes and $58 in interest accrued on the notes have been converted to $9,257 in stock subscriptions receivable and $489 of bank fees.  No warrants have been exercised.


 

September 30, 2010

 

June 30, 2010

 

 

 

 

Unsecured convertible notes payable with a 12% interest

 $                        295,000

 

 $                    295,000

rate and convertible at $0.20 per common share

 

 

 

 

 

 

 

Unsecured convertible notes payable with a 12% interest

                        1,647,218

 

                       565,500

rate and convertible at $0.25 per common share

 

 

 

 

 

 

 

Note Discount

                            (59,103)

 

                       (16,301)

 

 $                              1,883,115

 

 $                    844,199


For the three months ended September 30, 2010 the Company issued attached warrants to purchase its common stock on issuance of convertible notes payable.  The warrants had an exercise price of $0.25 with a three year expiration and immediate vesting.  The fair value of each issuance is estimated on the date of grant using the Black-Scholes option pricing model. The Black-Scholes option pricing model incorporates assumptions for each input. Expected volatilities are based on the historical volatility of the Company’s common equity traded on the OTC market. The Company estimates expected life of each warrant based on the midpoint between the dates the warrant vests and the contractual term of the warrant. The risk-free interest rate represents the U.S. Treasury bill rate for the expected life of the related warrant.


The warrants were issued throughout the three months ended September 30, 2010 and the Black-Scholes option pricing model inputs were used on the date of issuance which ranged over the period for the following assumptions: stock price on the measurement date was between $0.01 and $0.20; expected term of three years; average expected volatility was 228%; and discount rate of 0.82% for the three months ended September 30, 2010.  During the three months ended September 30, 2010 the fair value of the warrants issued with convertible notes payable was calculated at $46,378, recorded as a discount to the notes to which they were attached.




9




The following table summarizes information about the warrants as of September 30, 2010 and June 30, 2010:

 

Shares Under Warrants

 

Weighted Average Exercise Price

 

Weighted Average Remaining Contractual Life

 

Aggregate Intrinsic Value

Outstanding as of June 30, 2010

     934,250

 

 $        0.23 

 

 2.75 Years

 

 $              -

Granted

  1,091,464

 

 $        0.25

 

 2.75 Years

 

 

Expired

                 -

 

 $              -

 

 

 

 

Exercised

                 -

 

 $              -

 

 

 

 

Outstanding as of September 30, 2010

  2,025,714

 

 $        0.25

 

 2.50 Years

 

 $              -

Exercisable as of September 30, 2010

  2,025,714

 

 $        0.25

 

 2.50 Years

 

 $              -


The year-end intrinsic values are based on a September 30, 2010 closing price of $0.175 per share.


5.  Name Change and Reverse Stock Split


On September 19, 2007, the Company filed a certificate of amendment to the Company’s Articles of Incorporation with the Secretary of State of the State of Minnesota to (i) change its name from Implant Technologies, Inc. to Oasis Online Technologies Corp and (ii) give notice of a one-for-eight reverse stock split of the Company’s common shares.

  

Upon effectiveness of the one-for-eight reverse stock split, all issued and outstanding shares, as of the effective date, were reduced from 99,438,464 prior to the reverse split to 12,429,808 following the reverse stock split. No fractional shares were issued. In lieu of issuing fractional shares, the Company issued to any stockholder who otherwise would have been entitled to receive a fractional share as a result of the reverse stock split an additional full share of its common stock. The number of authorized shares of common stock of the Company was reduced by the same eight for one ratio as the issued and outstanding shares of common stock. The name change became effective and the Company began using the new name on September 19, 2007. The reverse split became effective on September 26, 2007. All references in the accompanying financial statements to the number of common shares and per share amounts have been retroactively adjusted to reflect the reverse stock split.


On November 4, 2010 the Company changed its name to Capital Group Holdings, Inc.


6. Leases


At December 21, 2007, the Company signed a new operating lease for its headquarters facilities that expired December 31, 2010. Under the terms of the lease agreement, the Company was



10




responsible for its share of normal operating costs, including maintenance expenses, property taxes and insurance. Rent for the first 12 months was $817 per month which included city tax and a parking fee. The rent for the remaining 24 months was $881 per month including tax and parking. The lease agreement included a $775 security deposit.  A new lease for the facility was executed on March 5, 2010 for a period of two years with the lease ending March 5, 2012.  Rent was $2,500 per month with a security deposit of $7,250.  Under the terms of the lease agreement, the Company was responsible for its share of normal operating costs, including maintenance expenses, property taxes and insurance.


Future minimum lease payments were as follows:


October 2010 through June 2011

$22,500

July 2011 through March 2012

$22,500


The Company incurred rent expense on the headquarters facility of $7,500 and $552 for the three months ended September 30, 2010 and 2009, respectively.


7. Agreements


On September 24, 2010, the Company entered into an agreement to acquire Main Street Family Pharmacy LLC (“Main Street”) for consideration of $300,000 in cash and 4,000,000 shares of common stock.  The acquisition agreement included employment agreements with the principals of Main Street Family Pharmacy.  Prior to the closing of the final agreement subsequent to September 30, 2010, management determined that the acquisition was not in the best interest of the Company and the transaction was rescinded.  An additional $111,000 of consideration was paid to Main Street, of which $83,000 was repaid.  On the rescission of the agreement, $266,735 of the initial $300,000 was repaid by Main Street Family Pharmacy to Capital Group and no common shares were issued.  As of September 30, 2010 the Company paid $200,000 of the initial $300,000 in deposits to Main Street and recorded the amount as other assets pending due diligence work.  Additionally, as of September 30, 2011, the Company paid $20,230 of the $111,000 of additional consideration paid to Main Street and their vendors and recorded the amount as due diligence costs on rescinded purchases for the three months ended September 30, 2010.


In July 2010 through March 2011 the Company advanced payments in the amount of $71,829 with the anticipation of an acquisition of Giovanni Medical Services and Lab Testing.  After due diligence, it was determined that acquiring Giovanni Medical Services and Lab Testing was not in the best interest of the Company.  As of September 30, 2010, the Company recorded $30,000 of payments to Giovanni as other assets with the remaining $41,829 paid subsequent to September 30, 2010.

    

8.  Related Party Transactions


On August 9, 2007, the Company entered into a Capital Base Funding Agreement with its largest single shareholder, Big Eye Capital, Inc. (“Big Eye”) whereby Big Eye would make available to the Company up to one hundred thousand dollars ($100,000) in working capital in exchange for newly issued common stock of the Company. The amount of common stock of the Company to



11




be issued to Big Eye would be based on the greater of the previous day’s closing market prices or $1.00 per share. The Company would give Big Eye ten days advance notice prior to requesting funds (when possible) so that not all funds would be advanced at any one time.  The Agreement was still in effect as of September 30, 2010.


In connection with the Capital Base Funding Agreement which ended on December 31, 2007, Big Eye Capital, Inc. provided a total of $51,046 of funding to the Company resulting in Big Eye Capital, Inc. being issued 51,046 shares of the Company’s common stock accordingly.  As of September 30, 2010 and 2009 there was $48,954 available under the Agreement.


9.  Subsequent Events


Subsequent to September 30, 2010 the Company issued $536,500 in convertible notes payable convertible at $0.25 per share with 536,500 attached warrants exercisable at $0.25 per share. Convertible notes payable of $2,483,464 were converted for 10,736,079 common shares with $5,000 in notes outstanding.


Subsequent to September 30, 2010, the Company issued 8,650,000 common shares in exchange for services valued at $1,711,500 based on the trading as of the date of issuance.  The Company issued 1,148,834 shares of common stock for $334,500 of cash and received $185,000 in cash for common shares to be issued.  The Company issued 10,000,000 shares to officers and directors as compensation and incentive valued at $200,000.


Subsequent to September 30, 2010, the Company paid $100,000 in consideration to Main Street Family Pharmacy LLC as a deposit to contemplate an acquisition.  An additional $111,000 of consideration was paid to Main Street, of which $83,000 was repaid.  On the rescission of the agreement, $266,735 of the initial $300,000 was repaid by Main Street Family Pharmacy to Capital Group and no common shares were issued.  Subsequent to September 30, 2011 the Company recorded $61,265 as due diligence cost on rescinded purchases.


Subsequent to September 30, 2010, the Company advanced payments in the amount of $41,829 with the anticipation of an acquisition of Giovanni Medical Services and Lab Testing.  After due diligence, it was determined that acquiring Giovanni Medical Services and Lab Testing was not in the best interest of the Company.  The Company recorded a loss in the statement of operations subsequent to September 30, 2010 for $71,829 as due diligence cost on rescinded purchases.  

 

On November 4, 2010 the Company changed its name to Capital Group Holdings, Inc.


On April 12, 2012, the Company entered into a joint marketing agreement with a health care provider to acquire customers.  The care provider will provide a total of $190,000 to be included in the advertising program that the Company will initiate in Arizona.  Net revenues collected from the customers the Company signs up for services under the marketing agreement shall be split with 51% paid to the Company and 49% paid to the care provider.  Unless terminated in writing 30 days prior to the end of the 36 month term, the Agreement will automatically renew for additional one (1) year terms.





12




Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.


Forward-looking Statements


Statements made in this Quarterly Report which are not purely historical are forward-looking statements with respect to the goals, plan objectives, intentions, expectations, financial condition, results of operations, future performance and our business, including, without limitation, (i) our ability to raise capital, and (ii) statements preceded by, followed by or that include the words “may,” “would,” “could,” “should,” “expects,” “projects,” “anticipates,” “believes,” “estimates,” “plans,” “intends,” “targets” or similar expressions.


Forward-looking statements involve inherent risks and uncertainties, and important factors (many of which are beyond our control) that could cause actual results to differ materially from those set forth in the forward-looking statements, including the following: general economic or industry conditions, nationally and/or in the communities in which we may conduct business, changes in the interest rate environment, international gold prices, legislation or regulatory requirements, conditions of the securities markets, our ability to raise capital, changes in accounting principles, policies or guidelines, financial or political instability, acts of war or terrorism, other economic, competitive, governmental, regulatory and technical factors affecting our current or potential business and related matters.


Accordingly, results actually achieved may differ materially from expected results in these statements. Forward-looking statements speak only as of the date they are made.  We do not undertake, and specifically disclaim, any obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of such statements.


Overview


We intend to offer a suite of secure, online products that provide consumers with the tools to more effectively manage their health and wellness as well as the ability to manage their personal health records, from all of their healthcare providers whether paper-based or digital. We are part of a trend where people are increasingly trusting on-line services as a way for them to store and manage critical, sensitive information such as medical records, financial records and vital documents.


Our suite of secure, web-based products all are built on an open source technology that allows users, including consumers, affinity groups, membership organizations, small businesses, physicians and health care professionals to easily store and organize information.  Our consumer products are built around our trademarked “OneHealthPass” Brand.  Our planned site will consist of www.OneHealthPass.com.    


OneHealthPass is an easy-to-use, secure web-based Personal Health Record system, or “PHR”, which allows documents, images and voice mail messages to be transmitted in and out of our system using a variety of methods, including fax, voice and file upload. OneHealthPass converts documents it receives by fax into Adobe's Portable Digital Format, or PDF, file. These files, as well as voice files and any other uploaded files are stored in the consumer's personal account,



13




which is secured by a unique user ID and password combination. A notification is sent to up to three user e-mail addresses (including to e-mail enabled cell and smart phones) whenever a new record is received.


Users can then access their files via the Internet and take advantage of an intuitive, customized filing system that allows them to categorize, annotate and file their records for easy access, organization and retrieval. Users can then print, download, e-mail or fax their records from their account, giving our customers greater control over their own personal health records and other information, which they can share with health care providers and others as they move through the continuum of care.


We plan to initially sell our OneHealthPass Telemedicine product primarily direct to consumers through a direct response advertising campaign.


We recognize the critical nature of managing an individuals' health information requires that our products and advances be implemented with the utmost care to protect the privacy and confidentiality of our customers' data. The Health Insurance Portability and Accountability Act of 1996, commonly referred to as HIPAA, requires covered entities to protect the privacy and confidentiality of protected health information, or PHI, of their patients and customers. Although we are not a covered entity (as that term is defined in HIPAA), we consider it important to take into account the Privacy and Security Standards and other requirements of HIPAA when implementing our products and services and believe that we meet and/or exceed current HIPAA standards.


The Health Information Technology for Economic and Clinical Health Act, commonly referred to as HITECH, enacted on February 17, 2009 as part of the American Recovery and Reinvestment Act, expanded HIPAA's reach beyond that of just covered entities. Now, business associates, defined as an entity that performs a function, activity, or service on behalf of a covered entity and that requires use or access to the information of the covered entities, and vendors of Personal Health Records that use or access information, must also comply with the Privacy and Security Standards of HIPAA. One of the key obligations under HITECH is the requirement to notify individuals when there has been (or there is a strong possibility of) a breach of the individual's information.


While we only rarely function as a business associate to a covered entity, we continue to meet and/or exceed the current HIPAA standards. Further, as a vendor of PHRs, we are implementing policies and procedures and reviewing our relationships with all necessary parties to ensure our compliance with HITECH and its associated regulations.


We plan to continue to take advantage of the burgeoning consumer health information market and leverage recent federal legislation, including the HITECH Act. We believe that the health care reform legislation recently passed by Congress and signed by the President into law represents a significant behavioral shift in how consumers manage their health care because of the requirement that everyone have insurance. We also believe that as medical costs and insurance costs increase, and benefits decrease, healthcare consumers will require greater control over their personal (and their family's) health information.



14





OneHealthPass with its dynamic PHR enable consumers to store their important medical records and data in one central and secure place where they can manage those records and control how they are accessed and shared. While every healthcare consumer in the U.S., as well as other countries that are focused on health information technology, are potential users of our OneHealthPass Platform, we believe that the product has most appeal to these particular market niches:


·

The chronically ill and their families who share information among many doctors; this "co-morbid population" represents a disproportionate share of U.S. health care costs;


·

Individuals with Health Savings Accounts who need to carefully manage their eligible expenses over the course of a year;


·

Consumers with "senior" parents who, in their role as caregivers, want to be sure they have current medical information readily available to react quickly in case of parental illness;


·

Consumers with newborns who will be able to build a complete medical file for the newborn, which can last the newborn's entire life;


·

Employees who are forced to change doctors and other providers when their employer changes health insurance and who therefore need to manage the transfer of medical information to their new providers;


·

Travelers and businesspeople working overseas who want to ensure that they always have access to their medical records in the event of an emergency.


Our Products


Telemedicine Services   The Company intends to contract with strategic alliance partners throughout the country to provide access to our members and customers with the best and broadest market coverage for telemedicine services.


Specialist referral services typically involves a specialist assisting a general practitioner in rendering a diagnosis. This may involve a patient "seeing" a specialist over a live, remote consult or the transmission of diagnostic images and/or video along with patient data to a specialist for viewing later. Recent surveys have shown a rapid increase in the number of specialty and subspecialty areas that have successfully used telemedicine. Radiology continues to make the greatest use of telemedicine with thousands of images "read" by remote providers each year. Other major specialty areas include: dermatology, ophthalmology, mental health, cardiology and pathology. According to reports and studies, almost 50 different medical subspecialties have successfully used telemedicine. 


The patient consultations use telecommunications to provide medical data, which may include audio, still or live images, between a patient and a health professional for use in rendering a



15




diagnosis and treatment plan. This might originate from a remote clinic to a physician's office using a direct transmission link or may include communicating over the Web. 


Remote patient monitoring uses devices to remotely collect and send data to a monitoring station for interpretation. Such "home telehealth" applications might include a specific vital sign, such as blood glucose or heart ECG or a variety of indicators for homebound patients. Such services can be used to supplement the use of visiting nurses. 


Medical education provides continuing medical education credits for health professionals and special medical education seminars for targeted groups in remote locations. 


Consumer medical and health information includes the use of the Internet for consumers to obtain specialized health information and on-line discussion groups to provide peer-to-peer support.


Benefits of Telemedicine


Telemedicine has been growing rapidly because it offers three fundamental benefits:


Improved Access   For over 40 years, telemedicine has been used to bring healthcare services to patients in distant locations. Not only does telemedicine improve access to patients but it also allows physicians and health facilities to expand their reach, beyond their own offices.


Cost Efficiencies   Reducing or containing the cost of healthcare is one of the most important reasons for funding and adopting telehealth technologies. Telemedicine has been shown to reduce the cost of healthcare and increase efficiency through better management of chronic diseases, shared health professional staffing, reduced travel times, and fewer or shorter hospital stays.


Patient Demand   Consumers want telemedicine. The greatest impact of telemedicine is on the patient, their family and their community. Using telemedicine technologies reduces travel time and related stresses to the patient. Over the past 15, years study after study has documented patient satisfaction and support for telemedical services. Such services offer patients the access to providers that might not be available otherwise as well as medical services without the need to travel long distances.


OneHealthPass Additional Features


OneHealthPass will offer users multiple ways to enter their personal medical information, including by voice or digital file upload.  We believe this capability makes OneHealthPass easier to use than other products in the marketplace and makes our product's information storage features more accessible to potential customers. In addition to the core document conversion, storage and retrieval capabilities, OneHealthPass provides a layer of useful, value-added interactive tools to help users better manage their personal and/or their families' medical records.




16




These tools include:


Ability to Attach Received Faxes to e-mail Notifications   Users can elect to have records attached to the notification e-mail they receive when a new medical record is received into their account. This capability is intended to save users the extra step of logging into their account to view new records, which we believe creates a higher level of convenience and usability.


Health History   Users can enter their personal health history, including information about doctors (such as a doctor's name, address and specialty), vaccinations and immunizations, hospitalizations/surgeries, allergies and medical conditions that may affect ongoing healthcare.


Appointment Calendar Feature   Users are able to take advantage of a calendar feature to schedule and generate reminders about upcoming doctor and other health-related appointments. These reminders appear when a user logs into his or her OneHealthPass PHR account and also can be sent to the user's e-mail address (or e-mail enabled cell phone) and imported into Microsoft Outlook.


Prescription History and Refill Reminder Feature   Users are able to enter their prescriptions, pharmacies and refill dates into their OneHealthPass accounts. The system generates reminders about refills, which are visible to users when they log into their accounts and are sent to their e-mail addresses (or e-mail enabled cell phone).


Drug Information and Interaction Database   Users can check for potential interactions across multiple prescriptions and over the counter drugs with this comprehensive database, licensed from Multum. When each user adds a new drug to their MMR PHR prescription history, they can quickly determine if that medication has any kind of negative interaction with other prescriptions they take. This tool is especially vital because drug interactions kill as many as 100,000 Americans each year and consumers who see multiple providers are especially at risk.


Voice Reminders and Messaging   We believe our OneHealthPass Records PHR product may create more efficient communication between doctors and patients. In addition to using a patient's personal OneHealthPass Records PHR telephone number to fax health information to a patient's secure on-line account, people can use the telephone number to leave a voice message, such as an appointment reminder, in a secure voice mailbox that is only accessible by the OneHealthPass PHR user. Users can also take advantage of this feature to leave themselves a reminder message such as for a doctor appointment or prescription refill reminder. Our OneHealthPass PHR product is designed to send a user a notification via e-mail when he or she receives a voice message. This gives users a helpful tool that they can access remotely.


Secondary Passwords on Selected File Folders   Users can assign a second password to four of the file folders in their OneHealthPass PHR account. This feature creates an additional layer of security for personal vital or medical documents that a OneHealthPass PHR user does not want a doctor to have access to in the event that the user has given the doctor access to the account, or if the user does not want other family members to be able to see selected information.




17




Emergency Log-In For Physicians and Other Emergency Response Personnel   Users can create a special password, discretely associated with each family member, which doctors and other emergency response personnel can use to gain access to the particular family member's medical records in the event of a medical emergency. This password grants access to an account but does not allow any additions, changes or deletions to be made to the account. In addition, users can decide which records a doctor will be able to see in an emergency situation. Users can write this password on an emergency sticker they receive when they enroll in our OneHealthPass PHR service, which can be affixed to a driver's license or personal ID. Users can even include a photograph in their emergency profile.


Health Information Library   Users have access to an interactive audio and visual encyclopedia, licensed from a third-party, of over 2,000 health information topics presented in both English and Spanish.


U.S. Healthcare Market


On March 23, 2010, President Obama signed into law a major overhaul of the United States health care and health insurance industries. As part of this overhaul, we anticipate that there will be an increased demand for the cost savings inherent in the use of electronic medical records, particularly the benefits to patients by having a personal health record. Also on February 17, 2009, President Obama signed into law the American Reinvestment and Recovery Act of 2009, or the ARRA, representing the largest government-driven investment in electronic healthcare technologies. Within ARRA, the Health Information Technology for Economic and Clinical Health Act, or HITECH, provisioned more than $19 billion in incentives to healthcare organizations that modernize their medical records systems through the widespread use of health information technology, or HIT. Throughout the process of healthcare reform, the challenge to rein in healthcare expenses will continue to be the nation's long-term fiscal challenge and this creates opportunities for HIT solutions that are shown to create greater efficiencies in care, safety and costs.


Our marketing strategy for our OneHealthPass calls for focus on four sales channels:


Direct to Consumer Marketing   We intend to continue to focus on marketing our OneHealthPass directly to consumers via both on-line and off-line advertising vehicles. OneHealthPass is currently available to individuals on a monthly or annual subscription basis.


Corporate Sales and Employee Benefit Offering    We are pursuing the human resources and benefits market to secure agreements or strategic arrangements providing for companies to offer our product to their employees and members. We believe the user-friendly nature of OneHealthPass makes it readily acceptable to employees and gives companies a low cost way to demonstrate their employee-friendliness.


Affinity Groups and Membership Organizations   OneHealthPass can be bundled with other health or travel-related services. For example, a travel accident insurance company can include our OneHealthPass in its suite of emergency medical and repatriation services for travelers going abroad. We believe giving users the ability to access their medical records in an emergency



18




situation overseas may add considerable value to an insurance company's travel insurance policies. Additionally, an affinity group, such as an alumni association, may offer OneHealthPass as a recruitment or renewal tool.


Private Label Branding   OneHealthPass is designed to allow site pages to be customized with a corporate, affinity group or membership organization logo and content that is specific to that entity. The technology built into OneHealthPass also is designed to allow companies, groups or organization to instantly communicate with hundreds or even thousands of employees in the event of an announcement or emergency situation.


Critical Accounting Policies and Estimates


The preparation of our condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and judgments that affect our reported assets, liabilities, revenues, and expenses and the disclosure of contingent assets and liabilities. We use assumptions we believe to be reasonable under the circumstances. Future events, however, may differ markedly from our current expectations and assumptions. We believe there have been no significant changes in accounting policies during the period ended September 30, 2010.  


Recently Issued Accounting Standards


The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its consolidated financial statements.


Results of Operations


During the three months ended September 30, 2010, we incurred a net loss of $1,069,179 compared to net loss of $57,918 for the three months ended September 30, 2009. The increase in our net loss for the three months ended September 30, 2010 over the comparable period of the prior year is primarily due to the increased cost of wages, salaries, and services as a result of the Company obtaining funding to begin strategic acquisitions and perform due diligence and hire consultants and employees to begin developing the market for the Company’s products and technology.  Additional consulting, legal and accounting costs were also incurred for the three months ended September 30, 2010 over the same period 2009.

 

Liquidity and Capital Resources


Liquidity is a measure of a company’s ability to meet potential cash requirements. We have historically met our capital requirements through the issuance of stock and by borrowings.


Operating expenses for the Company have been paid from the issuance of stock and convertible notes payable of the Company. At September 30, 2010 the Company had a deficit in working capital (current liabilities in excess of current assets) of $2,219,410. The working capital deficit at June 30, 2010 was $1,386,025. The increase in working capital deficit when compared to June



19




30, 2010 was principally due to outstanding convertible notes payable, accrued salaries and accounts payable, offset by an increase in deposits paid for Main Street Pharmacy and  Giovanni Medical Services and Lab Testing.


Since inception, we have financed our cash flow requirements through issuance of common stock and notes payable. As we expand our activities, we may, and most likely will, continue to experience net negative cash flows from operations, pending generation of revenues. Additionally, we anticipate obtaining additional financing to fund operations through common stock offerings to the extent available or to obtain additional financing to the extent necessary to augment our working capital. In the future we need to generate sufficient revenues from sales in order to eliminate or reduce the need to sell additional stock or obtain additional loans.  There can be no assurance we will be successful in raising the necessary funds to execute our business plan.

    

As of September 30, 2010, the current assets increased by $304,035 when compared to June 30, 2010 due to the receipt of funding in the form of convertible notes payable, $230,000 of which were paid as deposits on contemplated transactions.


As of September 30, 2010, the current liabilities increased by $1,137,420 when compared to June 30, 2010 current liabilities.   The primary reason for the increase is  the issuance of convertible notes payable to investors used for funding general company operations, funding costs, and payment of deposits on contemplated transactions, along with the salaries payable and accounts payable for work on the platform technology and management of the Company.


We anticipate that we may incur operating losses during the next twelve months. The Company’s lack of operating history makes predictions of future operating results difficult to ascertain.  Our prospects must be considered in light of the risks, expenses and difficulties frequently encountered by companies in their early stage of development, particularly companies in new and rapidly evolving markets. Such risks include, but are not limited to, an evolving and unpredictable business model and the management of growth. These factors raise substantial doubt about our ability to continue as a going concern. To address these risks, we must, among other things, increase our customer base, implement and successfully execute our business and marketing strategy, respond to competitive developments, and attract, retain and motivate qualified personnel. There can be no assurance that we will be successful in addressing such risks, and the failure to do so can have a material adverse effect on our business prospects, financial condition and results of operations.


Going Concern


The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplates continuation of the Company as a going concern. Since we have not generated any revenue, we have negative cash flows from operations, and negative working capital, we have included a reference to the substantial doubt about our ability to continue as a going concern in connection with our consolidated financial statements for the quarter ended September 30, 2010. Our total accumulated deficit at September 30, 2010 was $7,184,310.




20




The accompanying condensed consolidated financial statements have been prepared on the going concern basis, which assumes that adequate sources of financing will be obtained as required and that our assets will be realized, and liabilities settled in the ordinary course of business.  If we are unable to obtain additional financing we may cease operations and not be able to execute on operating plans. Accordingly, the condensed consolidated financial statements do not include any adjustments related to the recoverability of assets and classification of assets and liabilities that might be necessary should we be unable to continue as a going concern.


The Company had not been compliant with SEC reporting deadlines, but management has opted to make the necessary filings to be become compliant with the Securities and Exchange Commission (SEC) reporting guidelines to allow the Company to raise capital in order to execute on the Company’s business strategy.  Management is attempting to raise capital, secure strategic alliances, and to operate the business strategy, however no there is no assurance that these will be obtained.


Item 3.  Quantitative and Qualitative Disclosures About Market Risk.


Not required.


Item 4.  Controls and Procedures.


Evaluation of disclosure controls and procedures


Our management, with the participation of our chief accounting and executive officers evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) under the Exchange Act as of the end of the period covered by this Quarterly Report on Form 10-Q.  In designing and evaluating the disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.  In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.


Based on that evaluation, our chief accounting and chief executive officers concluded that, as of September 30, 2010, our disclosure controls and procedures were, subject to the limitations noted above, not effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules, regulations and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief accounting officer, as appropriate, to allow timely decisions regarding required disclosure.




21




Changes in internal control over financial reporting


There have been no changes in internal control over financial reporting during the three months ended September 30, 2010.


PART II - OTHER INFORMATION


Item 1. Legal Proceedings.


The Company is presently not party to any legal proceedings.


Item 1A.  Risk Factors.


For a discussion of the Company’s risk factors, please refer to Part 1, “Item 1A. Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2010, filed on July 18, 2012.  There has been no material changes in the Company’s assessment of its risk factors during the quarter ended September 30, 2010.


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.


During the three months ended September 30, 2010 the Company did not sell any shares of unregistered equity securities.


Item 3. Defaults Upon Senior Securities.


None; not applicable.


Item 4. Mine Safety Disclosures


 None; not applicable.


Item 5. Other Information.


None



22




Item 6. Exhibits.


Index to Exhibits:


Exhibit

Number

 

Description of Exhibit

  

  

3.1

Articles of Incorporation (incorporated by reference to the exhibits to Registrant's Form 8-K filed on October 3, 2007).

  

  

3.2

By-Laws (incorporated by reference to the exhibits to Registrant's Form 10-SB filed on December 14, 2006).

  

  

31.1

Certification of Principal Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities and Exchange Act of 1934, as amended

  

  

31.2

Certification of Principal Accounting Officer pursuant to Rule 13a-14 and Rule 15d 14(a), promulgated under the Securities and Exchange Act of 1934, as amended

  

  

32.1

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer)

  

  

32.2

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Accounting Officer)





























23




SIGNATURES


Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


CAPITAL GROUP HOLDINGS. INC. FKA OASIS ONLINE TECHNOLOGIES CORP


July 31, 2012

/s/ Erik J. Cooper

By:

Erik J. Cooper

Its:

Chairman

President

Chief Executive Officer


Pursuant to the requirements of the Securities Exchange Act of 1934 this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.


CAPITAL GROUP HOLDINGS. INC. FKA OASIS ONLINE TECHNOLOGIES CORP



July 31, 2012

/s/ Erik J. Cooper

By:

Erik J. Cooper

Its:

Chairman

President

Chief Executive Officer

  

  

  

/s/ Eric Click

By:

Eric Click

Its:

Director

Secretary

Treasurer

Chief Operating Officer

Principal Accounting Officer





















24